YYYorimasa Yamamoto

Yorimasa Yamamoto

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article

Previous Organizations / Institutes

The organizations / institutes from the scholar's other articles in the past ten years


Yorimasa Yamamoto has a total of 75 co-authors. Here are the top co-authors by number of shared publications:


Latest Publications

  • Utility of magnifying endoscopy with narrow-band imaging for detection of gastric cancer in hyperplastic polyps

    by Kazuhisa Yamaguchi, Yorimasa Yamamoto, Yusuke Horiuchi, Masami Omae, Akiyoshi Ishiyama, Toshiaki Hirasawa, Toshiyuki Yoshio, Tomohiro Tsuchida, Junko Fujisaki, Masahiro Igarashi

    A 77-year-old man, who had undergone a distal gastrectomy in 1997 because of advanced gastric cancer, was referred to our hospital for endoscopic resection of a metachronous gastric cancer. Upper gastrointestinal endoscopy revealed a 20-mm reddish polyp located at the greater curvature of the gastrectomy site of the residual stomach. Magnifying endoscopy with narrow-band imaging (ME-NBI) revealed a regular structure at the anal side of the polyp, resembling a hyperplastic polyp. Thus, irregular surface and vascular structure were observed at the oral side of polyp, indicating gastric cancer. In addition, we noted a gradual gradation between the hyperplastic lesion and the cancerous lesion by ME-NBI. Considering all these findings, we speculated that the hyperplastic polyp had progressed to adenocarcinoma. Endoscopic mucosal resection was performed, and histological analysis confirmed the diagnosis of adenocarcinoma. Thus, ME-NBI can be useful for detection of gastric cancer developing in hyperplastic polyps.

  • Helicobacter pylori‐negative gastric cancer: Characteristics and endoscopic findings

    by Yorimasa Yamamoto, Junko Fujisaki, Masami Omae, Toshiaki Hirasawa, Masahiro Igarashi

    Helicobacter pylori (H. pylori) leads to chronic gastritis and eventually causes gastric cancer. The prevalence of H. pylori infection is gradually decreasing with improvement of living conditions and eradication therapy. However, some reports have described cases of H. pylori‐negative gastric cancers (HpNGC), and the prevalence was 0.42–5.4% of all gastric cancers. Diagnostic criteria of HpNGC vary among the different reports; thus, they have not yet been definitively established. We recommend negative findings in two or more methods that include endoscopic or pathological findings or serum pepsinogen test, and negative urease breath test or serum immunoglobulin G test and no eradication history the minimum criteria for diagnosis of HpNGC. The etiology of gastric cancers, excluding H. pylori infection, is known to be associated with several factors including lifestyle, viral infection, autoimmune disorder and germline mutations, but the main causal factor of HpNGC is still unclear. Regarding the characteristics of HpNGC, the undifferentiated type (UD‐type) is more frequent than the differentiated type (D‐type). The UD‐type is mainly signet ring‐cell carcinoma that presents as a discolored lesion in the lower or middle part of the stomach in relatively young patients. The gross type is flat or depressed. The D‐type is mainly gastric adenocarcinoma of the fundic gland type that presents as a submucosal tumor‐like or flat or depressed lesion in the middle and upper part of the stomach in relatively older patients. Early detection of HpNGC enables minimally invasive treatment which preserves the patient's quality of life. Endoscopists should fully understand the characteristics and endoscopic findings of HpNGC.


  • Endoscopic response evaluation of gastric primary lesion for chemotherapy compared to CT in advanced gastric cancer.

    by Keisho Chin, Yorimasa Yamamoto, Junko Fujisaki, Mariko Ogura, Eiji Shinozaki, Mitsukuni Suenaga, Nobuyuki Mizunuma

    50 Background: Significance of evaluation of gastric primary lesion with endoscopy remains unclear in chemotherapy (CTx) for advanced gastric cancer (AGC). Endoscopic evaluation is not necessary in RECIST. Methods: We compare the response of chemotherapy using RECIST by CT with or without upper GI endoscopy in AGC cases retrospectively. Among 175 cases of unresectable AGC treated by CTx in our institution between 2004 and 2008, we reviewed 141 evaluations in 74 cases which were examined by both endoscopy and CT within 2 weeks before and after CTx. Results: Patient backgrounds: Gender; M47/F27, Age; median 59(24-75), PS; 0or1=71/2=3, histological type; intestinal28/diffuse46, metastatic site; LN47/liver26/peritoneum29, CT per case; median number 4.5/ median interval 64.5days, endoscopy per case; median number 2/ median interval 91.3days. Response evaluation for gastric primary lesion between CT and endoscopy was compared in 141 examinations. Identical response 123(87.2%); both non-CR/non-PD 101/ both PD 22, not identical response 10(7.1%); endoscopy PD /CT non-CR/non-PD 10, not detected by CT; 8(5.7%). All of the cases of not identical response between CT and endoscopy were PD in endoscopy whereas non-CR/non-PD in CT. The overall response evaluation with or without endoscopy was concord in 133 evaluations (94.3%). Conclusions: It is almost appropriate that response evaluation of chemotherapy in AGC is mainly performed by CT without endoscopy to primary gastric lesion.

  • Open Access

    Therapeutic outcomes of endoscopic resection for superficial non‐ampullary duodenal tumor

    by Yorimasa Yamamoto, Natsuko Yoshizawa, Hideomi Tomida, Junko Fujisaki, Masahiro Igarashi

    Background and Aim: Endoscopic resection (ER) is widely used as a minimally invasive therapy to remove superficial non‐ampullary duodenal tumor (SNADT). However, the indication criteria have not yet been clearly determined. At our institute, ER is done only for SNADT measuring ≤20 mm. We report our findings on the therapeutic outcomes of ER of SNADT.Methods: We carried out ER in 47 patients with SNADT. Indication criteria for ER included a lesion suspected as high‐grade dysplasia or mucosal cancer and measuring ≤20 mm. The ER methods used to carry out en bloc resection were endoscopic mucosal resection (EMR: 17 lesions) or endoscopic submucosal dissection (ESD: 30 lesions). We then analyzed the therapeutic outcomes between them.Results: There were no significant differences between the EMR and ESD groups with regard to age, sex, location of the lesion, and histology. The most frequent gross types resected by EMR and ESD were 0‐IIa and 0‐IIc, respectively (P = 0.004). Median procedure time was significantly longer in ESD than in EMR, 79.5 and 9 min, respectively (P < 0.001). R0 resection was achieved in 10 cases by EMR (59%) and in 27 cases by ESD (90%) (P = 0.017). No complications occurred in cases that underwent EMR, but immediate and delayed perforations occurred in three patients who underwent ESD, although this difference was not statistically significant (P = 0.467).Conclusion: Using our indication criteria, which limited lesion size to ≤20 mm, satisfactory therapeutic outcomes of ER of SNADT were obtained.


  • Adenoma progressing to early duodenal carcinoma over a five year period

    by Kenjiro Morishige, Yorimasa Yamamoto, Yusuke Horiuchi, Hirotaka Ishikawa, Natsuko Yoshizawa, Masami Omae, Akiyoshi Ishiyama, Toshiyuki Yoshio, Toshiaki Hirasawa, Tomohiro Tsuchida, et al.

    A 59-year-old man was referred in 2007 to our hospital with duodenal adenoma. Esophagogastroduodenoscopy (EGD) showed a slightly elevated whitish lesion at the 2nd portion of the duodenum. The lesion was 15 mm in size and appeared to be accompanied by a scar. Biopsy showed low grade adenoma and hence the lesion was monitored. On endoscopic examination, it gradually changed to a reddish color and became more depressed. In 2012, the lesion was examined using a magnifying endoscope with narrow band imaging (ME-NBI) . This revealed an irregular microvascular pattern of the lesion. At this stage the lesion was diagnosed as a cancer, and endoscopic biopsy of this identified well differentiated adenocarcinoma (tub1) . ESD was performed and the resected specimen showed D, 15 × 10 mm, Type 0-IIa, tub1, pT1a, ly (−) , v (−) , pHM0, pVM0. In this case, ME-NBI was useful to diagnose the cancer. The endoscopy was performed every one year. Repeated biopsy procedures result in fibrosis of the submucosal layer of the duodenum and may make subsequent ESD difficult. Consequently, we recommend the use of ME-NBI as optical biopsy for duodenal adenoma.


  • Endoscopic submucosal dissection for colorectal neoplasms accompanied with fibrosis in the subumucosal layer

    by Hirotaka Ishikawa, Yoshiro Tamegai, Akiko Chino, Kazuhisa Okada, Mizuka Imai, Teruhito Kishihara, Naoyuki Uragami, Yorimasa Yamamoto, Tomohiro Tsuchida, Junko Fujisaki, et al.

    大腸ESDの適応と限界を明らかにする目的で,粘膜下層に高度な線維化を伴う病変の臨床病理学的特徴を検討した。対象は,2011年3月〜2012年4月に大腸ESDを施行した110例110病変のうち,粘膜下層に線維化を認めた23例の内視鏡像をretrospectiveに検討し,ESDによる一括切除の成否を分けた要因を分析した。高度線維化は9例に認められ,5例は一括切除が可能であったが,4例で分割切除あるいはESDの中止を余儀なくされた。一括切除例5例の内訳は,LST-NG:2例,LST-G:2例,Isp:1例で,pit patternは全例ⅤI軽度不整,深達度はpM癌3例,pSM1癌2例であった。分割切除/中止4例の内訳は,LST-NG:1例,LST-G:2例,Isp:1例で,pit patternはⅤI軽度不整2例,ⅤI高度不整2例,深達度はpM癌2例,pSM2癌2例で,ⅤI高度不整の2例がいずれもpSM2癌であった。手技的側面からの検討では,一括切除例5例では線維化領域における剥離線の設定が可能であったが,分割切除/中止の4例では剥離線の設定が困難であった。 以上よりⅤI高度不整を呈する高度線維化例は,根治的ESDの適応外であるSM高度浸潤癌の可能性が高く,撤退を考慮する指標になると考えられた。また高度線維化病変に対する一括切除の成否は,線維化領域の剥離線の設定が可能か否かによると考えられた。

  • Open Access

    CURRENT STATUS OF TRAINING FOR ENDOSCOPIC SUBMUCOSAL DISSECTION FOR GASTRIC EPITHELIAL NEOPLASM AT CANCER INSTITUTE HOSPITAL, JAPANESE FOUNDATION FOR CANCER RESEARCH, A FAMOUS JAPANESE HOSPITAL

    by Yorimasa Yamamoto, Junko Fujisaki, Akiyoshi Ishiyama, Toshiaki Hirasawa, Masahiro Igarashi

    Aim:  Endoscopic submucosal dissection (ESD) is relatively difficult compared with endoscopic mucosal resection (EMR), thus, proper training is essential for the safe performance of the procedure. The aim of this study is to clarify the current status of training for ESD for gastric epithelial neoplasm by following the performance of 13 preceptees.Methods:  We performed ESD for 1520 lesions between March 2005 and April 2011 and conducted ESD training of 13 preceptees who were supervised by experts. We classified the samples into four groups according to the number of ESD performed by the preceptees to chart their progress by comparing the procedural outcomes. Group A included cases 1–40 performed by all 13 preceptees, group B consisted of cases 41–80 performed by 10 of the preceptees and group C included cases 81 onwards executed by five of the preceptees. Group D comprised the cases that were performed by experts during the same period as group C.Results:  The procedural outcomes of group A were similar to those of group B with regard to operation time, complete en bloc resection and complications. However, the results of group B included significantly more lesions of the middle or upper third of the stomach, resected specimen and lesions were larger in diameter, lesions with positive ulcer finding were more frequent and a higher frequency of lesions were of expanded, non‐indication type. Group B outcomes were similar to those of group C but differed in location of lesions and specimen size. Group C outcomes were similar to group D's in all parameters.Conclusion:  Preceptees were able to safely perform ESD for gastric epithelium neoplasms under appropriate supervision by expert endoscopists. The number of cases in which preceptees successfully extracted guideline‐indication lesions and expanded‐indication lesions by ESD were approximately 40 and 80 cases, respectively. The procedural outcomes of ESD performed by preceptees who had experience in over 80 cases were similar to those by expert endoscopists. Thus, these findings show that the minimal amount of training for achieving preceptorship of ESD is performance of at least 80 of the procedures.


  • Sa1691 The Clinicopathological Findings of the Patient Who Needed Clip Hemostasis for Perioperative Bleeding During Endoscopic Submucosal Dissection for Early Gastric Cancer

    by Yasumasa Matsuo, Yorimasa Yamamoto, Chika Taniguchi, Kenjiro Morishige, Yusuke Horiuchi, Natsuko Yoshizawa, Takanori Suganuma, Manabu Kubota, Masami Nego, Kazuhisa Okada, et al.


  • Clinical characterization of gastric lesions initially diagnosed as low-grade adenomas on forceps biopsy

    by Akiyoshi Kasuga, Yorimasa Yamamoto, Junko Fujisaki, Kazuhisa Okada, Masami Omae, Akiyoshi Ishiyama, Toshiaki Hirasawa, Akiko Chino, Tomohiro Tsuchida, Masahiro Igarashi, et al.